{"count": 4, "results": [{"_id": "36907882", "pmid": 36907882, "pmcid": "PMC10008713", "title": "Re-analysis of ventilator-free days (VFD) in acute respiratory distress syndrome (ARDS) studies", "journal": "Trials", "authors": ["Verghis RM", "McDowell C", "Blackwood B", "Lee B", "McAuley DF", "Clarke M"], "date": "2023-03-13T00:00:00Z", "doi": "10.1186/s13063-023-07190-7", "meta_date_publication": "2023 Mar 13", "meta_volume": "24", "meta_issue": "1", "meta_pages": "183", "score": 50242.93, "text_hl": "Delayed Enteral Nutrition (EDEN), @GENE_HMGCR @GENE_3156 @@@Hydroxymethylglutaryl-CoA reductase@@@ inhibition with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ in @DISEASE_Acute_Lung_Injury @DISEASE_MESH:D055371 @@@Acute Lung Injury@@@ (@DISEASE_Acute_Lung_Injury @DISEASE_MESH:D055371 @@@ALI@@@) to reduce @<m>DISEASE_Pulmonary_Heart_Disease</m> @DISEASE_MESH:D011660 @@@pulmonary dysfunction@@@ (HARP-2), Statins for @DISEASE_Acute_Lung_Injury @DISEASE_MESH:D055371 @@@Acutely Injured Lungs from Sepsis@@@ (SAILS)) were used for analysis, with the VFD results summarised using mean, standard deviation (SD), median, interquartile range (25th and 75th percentiles) and minimum and maximum values. ", "citations": {"NLM": "Verghis RM, McDowell C, Blackwood B, Lee B, McAuley DF, Clarke M. Re-analysis of ventilator-free days (VFD) in acute respiratory distress syndrome (ARDS) studies Trials. 2023 Mar 13;24(1):183. PMID: 36907882", "BibTeX": "@article{36907882, title={Re-analysis of ventilator-free days (VFD) in acute respiratory distress syndrome (ARDS) studies}, author={Verghis RM and McDowell C and Blackwood B and Lee B and McAuley DF and Clarke M}, journal={Trials}, volume={24}, number={1}, pages={183}}"}}, {"_id": "38046206", "pmid": 38046206, "pmcid": "PMC10692599", "title": "The relationship between plasma cystatin C, mortality and acute respiratory distress syndrome subphenotype in the HARP-2 trial", "journal": "Crit Care Resusc", "authors": ["McKelvey MC", "Bradbury I", "McDowell C", "Calfee CS", "Weldon S", "O'Kane CM", "McAuley DF", "Taggart CC"], "date": "2023-10-18T00:00:00Z", "doi": "10.51893/2022.3.OA4", "meta_date_publication": "2022 Sep 5", "meta_volume": "24", "meta_issue": "3", "meta_pages": "251-258", "score": 50241.105, "text_hl": "Design, @SPECIES_9606 @@@patients@@@ and setting: A retrospective analysis was performed on plasma samples from @SPECIES_9606 @@@patients@@@ included in the HARP-2 (@GENE_HMGCR @GENE_3156 @@@hydroxymethylglutaryl-CoA reductase@@@ inhibition with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ in @DISEASE_Acute_Lung_Injury @DISEASE_MESH:D055371 @@@acute lung injury@@@ to reduce @<m>DISEASE_Pulmonary_Heart_Disease</m> @DISEASE_MESH:D011660 @@@pulmonary dysfunction@@@) trial : a multicentre, phase 2b trial carried out in general intensive care units across 40 hospitals in the United Kingdom and Ireland. ", "citations": {"NLM": "McKelvey MC, Bradbury I, McDowell C, Calfee CS, Weldon S, O'Kane CM, McAuley DF, Taggart CC. The relationship between plasma cystatin C, mortality and acute respiratory distress syndrome subphenotype in the HARP-2 trial Crit Care Resusc. 2022 Sep 5;24(3):251-258. PMID: 38046206", "BibTeX": "@article{38046206, title={The relationship between plasma cystatin C, mortality and acute respiratory distress syndrome subphenotype in the HARP-2 trial}, author={McKelvey MC and Bradbury I and McDowell C and Calfee CS and Weldon S and O'Kane CM and McAuley DF and Taggart CC}, journal={Crit Care Resusc}, volume={24}, number={3}, pages={251-258}}"}}, {"_id": "37695136", "pmid": 37695136, "title": "Elevated Plasma Interleukin-18 Identifies High-Risk Acute Respiratory Distress Syndrome Patients not Distinguished by Prior Latent Class Analyses Using Traditional Inflammatory Cytokines: A Retrospective Analysis of Two Randomized Clinical Trials.", "journal": "Crit Care Med", "authors": ["Moore AR", "Pienkos SM", "Sinha P", "Guan J", "O'Kane CM", "Levitt JE", "Wilson JG", "Shankar-Hari M", "Matthay MA", "Calfee CS", "Baron RM", "McAuley DF", "Rogers AJ"], "date": "2023-09-11T00:00:00Z", "doi": "10.1097/CCM.0000000000006028", "meta_date_publication": "2023 Sep 11", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50229.348, "text_hl": "DESIGN: Statins for @DISEASE_Acute_Disease @DISEASE_MESH:D000208 @@@acutely@@@ injured @DISEASE_Lung_Diseases @DISEASE_MESH:D008171 @@@lungs@@@ from @DISEASE_Sepsis @DISEASE_MESH:D018805 @@@sepsis@@@ (@DISEASE_Acute_Lung_Injury @DISEASE_MESH:D055371 @@@SAILS@@@) and @GENE_HMGCR @GENE_3156 @@@hydroxymethylglutaryl-CoA reductase@@@ inhibition with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ in @DISEASE_Acute_Lung_Injury @DISEASE_MESH:D055371 @@@acute lung injury@@@ to reduce @<m>DISEASE_Pulmonary_Heart_Disease</m> @DISEASE_MESH:D011660 @@@pulmonary dysfunction@@@ trial (HARP-2) are two large randomized, controlled trials in @DISEASE_Respiratory_Distress_Syndrome @DISEASE_MESH:D012128 @@@ARDS@@@ in which both LCA assignments and @GENE_IL18 @GENE_3606 @@@IL-18@@@ levels were shown to predict mortality. ", "citations": {"NLM": "Moore AR, Pienkos SM, Sinha P, Guan J, O'Kane CM, Levitt JE, Wilson JG, Shankar-Hari M, Matthay MA, Calfee CS, Baron RM, McAuley DF, Rogers AJ. Elevated Plasma Interleukin-18 Identifies High-Risk Acute Respiratory Distress Syndrome Patients not Distinguished by Prior Latent Class Analyses Using Traditional Inflammatory Cytokines: A Retrospective Analysis of Two Randomized Clinical Trials. Crit Care Med. 2023 Sep 11;():. PMID: 37695136", "BibTeX": "@article{37695136, title={Elevated Plasma Interleukin-18 Identifies High-Risk Acute Respiratory Distress Syndrome Patients not Distinguished by Prior Latent Class Analyses Using Traditional Inflammatory Cytokines: A Retrospective Analysis of Two Randomized Clinical Trials.}, author={Moore AR and Pienkos SM and Sinha P and Guan J and O'Kane CM and Levitt JE and Wilson JG and Shankar-Hari M and Matthay MA and Calfee CS and Baron RM and McAuley DF and Rogers AJ}, journal={Crit Care Med}}"}}, {"_id": "22985805", "pmid": 22985805, "pmcid": "PMC3543316", "title": "Hydroxymethylglutaryl-CoA reductase inhibition with simvastatin in Acute lung injury to Reduce Pulmonary dysfunction (HARP-2) trial: study protocol for a randomized controlled trial", "journal": "Trials", "authors": ["McAuley DF", "Laffey JG", "O'Kane CM", "Cross M", "Perkins GD", "Murphy L", "McNally C", "Crealey G", "Stevenson M", "HARP-2 investigators", "Irish Critical Care Trials Group"], "date": "2012-09-17T00:00:00Z", "doi": "10.1186/1745-6215-13-170", "meta_date_publication": "2012 Sep 17", "meta_volume": "13", "meta_issue": "", "meta_pages": "170", "score": 50057.54, "text_hl": "@GENE_HMGCR @GENE_3156 @@@Hydroxymethylglutaryl-CoA reductase@@@ inhibition with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ in @DISEASE_Acute_Lung_Injury @DISEASE_MESH:D055371 @@@Acute lung injury@@@ to Reduce @<m>DISEASE_Pulmonary_Heart_Disease</m> @DISEASE_MESH:D011660 @@@Pulmonary dysfunction@@@ (HARP-2) trial: study protocol for a randomized controlled trial", "citations": {"NLM": "McAuley DF, Laffey JG, O'Kane CM, Cross M, Perkins GD, Murphy L, McNally C, Crealey G, Stevenson M, HARP-2 investigators, Irish Critical Care Trials Group. Hydroxymethylglutaryl-CoA reductase inhibition with simvastatin in Acute lung injury to Reduce Pulmonary dysfunction (HARP-2) trial: study protocol for a randomized controlled trial Trials. 2012 Sep 17;13():170. PMID: 22985805", "BibTeX": "@article{22985805, title={Hydroxymethylglutaryl-CoA reductase inhibition with simvastatin in Acute lung injury to Reduce Pulmonary dysfunction (HARP-2) trial: study protocol for a randomized controlled trial}, author={McAuley DF and Laffey JG and O'Kane CM and Cross M and Perkins GD and Murphy L and McNally C and Crealey G and Stevenson M and HARP-2 investigators and Irish Critical Care Trials Group}, journal={Trials}, volume={13}, pages={170}}"}}]}